Ou Ling, Li Mengyang, Hou Yan
The First People's Hospital of Chenzhou, The First Affiliated Hospital of Xiangnan University, Chenzhou, China.
Heliyon. 2024 Mar 30;10(7):e28833. doi: 10.1016/j.heliyon.2024.e28833. eCollection 2024 Apr 15.
Globally, gastric cancer (GC) is recognized as the third leading cause of cancer-related deaths and the fifth most prevalent malignant disease. Multiple studies have indicated that Willd, in pinyin, called Bai Hua She Cao (BHSSC), a traditional Chinese medicine (TCM) is an herbal remedy for cancer treatment. However, the specific mechanisms underlying its anti-tumor properties and mode of action are still unclear.
To determine the role of BHSSC in GC, candidate target genes were selected from The Encyclopedia of Traditional Chinese Medicine (ETCM) and analyzed using network pharmacology, bioinformatics, and experimental validation. Differentially expressed genes (DEGs) associated with gastric cancer were obtained from RNA sequencing (RNA-seq) data sourced from The Cancer Genome Atlas-Stomach adenocarcinoma (TCGA-STAD). The Reactome Pathway was examined using Analysis Tools, while KEGG pathways were analyzed using KOBAS. Gene Ontology (GO) evaluations were performed using WebGestalt and DAVID. The relationships between proteins were investigated using the STRING database. Furthermore, cell viability, colony formation, and cell migration ability were conducted in gastric cancer cells, BGC-823 and MGC-803.
Network pharmacology and bioinformatics analyses revealed a significant association between BHSSC and metabolic pathways. experiments demonstrated that BHSSC effectively suppressed gastric cancer cell proliferation and colony formation, inhibited cell migration, and activated the endoplasmic reticulum (ER) stress. Furthermore, it was found that enhancement of the expression of IRE1α and BIP is the mechanism by which BHSSC activates ER stress.
The findings suggest that BHSSC exerts its effects through modulation of metabolic pathways, leading to the suppression of cell proliferation, inhibition of cell migration, and activation of the endoplasmic reticulum. These results provide valuable insights into the mechanisms underlying the therapeutic effects of BHSSC in GC and support its potential as a novel treatment option.
在全球范围内,胃癌(GC)被认为是癌症相关死亡的第三大主要原因,也是第五大最常见的恶性疾病。多项研究表明,一味名为白花蛇舌草(BHSSC)的中药是一种用于癌症治疗的草药。然而,其抗肿瘤特性和作用方式的具体机制仍不清楚。
为了确定白花蛇舌草在胃癌中的作用,从《中华本草》中选择候选靶基因,并使用网络药理学、生物信息学和实验验证进行分析。从癌症基因组图谱-胃腺癌(TCGA-STAD)的RNA测序(RNA-seq)数据中获得与胃癌相关的差异表达基因(DEG)。使用分析工具检查Reactome途径,同时使用KOBAS分析KEGG途径。使用WebGestalt和DAVID进行基因本体(GO)评估。使用STRING数据库研究蛋白质之间的关系。此外,在胃癌细胞BGC-823和MGC-803中进行细胞活力、集落形成和细胞迁移能力实验。
网络药理学和生物信息学分析表明白花蛇舌草与代谢途径之间存在显著关联。实验表明,白花蛇舌草有效抑制胃癌细胞增殖和集落形成,抑制细胞迁移,并激活内质网(ER)应激。此外,发现IRE1α和BIP表达的增强是白花蛇舌草激活ER应激的机制。
研究结果表明,白花蛇舌草通过调节代谢途径发挥作用,导致细胞增殖受到抑制、细胞迁移受到抑制以及内质网被激活。这些结果为白花蛇舌草在胃癌治疗中的作用机制提供了有价值的见解,并支持其作为一种新型治疗选择的潜力。